自己テスト:医療機器パイプライン分析2019

◆英語タイトル:Self Testing - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDATA9120295
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年11月
◆ページ数:81
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥530,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD7,500 ⇒換算¥795,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Self Testing – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Self Testing – Medical Devices Pipeline Assessment, 2019″ provides an overview of Self Testing currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development.

It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Self Testing pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Self Testing under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Self Testing and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Self Testing under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Self Testing Overview 6
3 Products under Development 7
3.1 Self Testing – Pipeline Products by Stage of Development 7
3.2 Self Testing – Pipeline Products by Territory 8
3.3 Self Testing – Pipeline Products by Regulatory Path 9
3.4 Self Testing – Pipeline Products by Estimated Approval Date 10
3.5 Self Testing – Ongoing Clinical Trials 11
4 Self Testing – Pipeline Products under Development by Companies 12
4.1 Self Testing Companies – Pipeline Products by Stage of Development 12
4.2 Self Testing – Pipeline Products by Stage of Development 13
5 Self Testing Companies and Product Overview 14
5.1 Atomo Diagnostics Pty Ltd Company Overview 14
5.1.1 Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 bioLytical Laboratories Inc Company Overview 18
5.2.1 bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 Boston Microfluidics Company Overview 20
5.3.1 Boston Microfluidics Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Brigham and Women’s Hospital Company Overview 21
5.4.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Emory University Company Overview 22
5.5.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 Entia Ltd Company Overview 23
5.6.1 Entia Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 InnaMed Inc Company Overview 24
5.7.1 InnaMed Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 Morgan Innovation And Technology Ltd Company Overview 26
5.8.1 Morgan Innovation And Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Novosanis NV Company Overview 27
5.9.1 Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 OncoGenesis Company Overview 28
5.10.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 28
5.11 Premier Medical Corporation Company Overview 29
5.11.1 Premier Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
5.12 Shanghai Kehua Bio-engineering Co Ltd Company Overview 30
5.12.1 Shanghai Kehua Bio-engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
5.13 Svenska Cellulosa Aktiebolaget Company Overview 31
5.13.1 Svenska Cellulosa Aktiebolaget Pipeline Products & Ongoing Clinical Trials Overview 31
5.14 Tasso, Inc. Company Overview 32
5.14.1 Tasso, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.15 Wellmetrix LLC Company Overview 33
5.15.1 Wellmetrix LLC Pipeline Products & Ongoing Clinical Trials Overview 33
6 Self Testing- Recent Developments 34
6.1 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 34
6.2 Aug 19, 2019: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech 35
6.3 Aug 12, 2019: Biocept reports second quarter 2019 financial results 35
6.4 Jul 25, 2019: Roche reports very strong performance in the first half of 2019 – Outlook raised 37
6.5 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 41
6.6 Jul 09, 2019: Mylan HIV Self Test receives WHO prequalification approval 42
6.7 Jun 14, 2019: Klobuchar, Murkowski introduce Legislation to Protect Consumers’ Private Health Data 42
6.8 Jun 11, 2019: Changes in Roche’s board of directors and corporate executive committee 44
6.9 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition 45
6.10 May 08, 2019: Biocept reports first quarter 2019 financial results 45
6.11 Apr 25, 2019: Regarding the establishment of the new “EIKEN ROAD MAP 2019″ management framework and the new medium-term management plan 47
6.12 Apr 25, 2019: Eiken Chemical announced its financial results for the fiscal year ended March 31, 2019 49
6.13 Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year 49
6.14 Apr 04, 2019: First HIV self-test approved for sale in Australia now available from Atomo Diagnostics 52
6.15 Mar 28, 2019: Biocept reports 2018 fourth quarter and full year financial results 53
6.16 Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips 57
6.17 Mar 13, 2019: EKF Diagnostics Holdings: Final results 57
6.18 Feb 27, 2019: Biocept and Providence Saint John’s Health Center collaborate to evaluate cerebrospinal fluid for use with liquid biopsy testing in metastatic cancer 62
6.19 Jan 31, 2019: Roche reports very strong results in 2018 63
6.20 Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer 67
6.21 Jan 11, 2019: Shimadzu’s new preparative purification LC System provides high efficiency, saves space, and enables multi-sample processing 68
6.22 Jan 07, 2019: MES to launch the first YO Home Sperm Test for PCs with personalized YO SCORE 69
6.23 Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager 70
6.24 Dec 13, 2018: Devicare announces the positive results of the clinical trial with Lit-Control to prevent the encrustation of catheters in patients with lithiasis 70
6.25 Dec 11, 2018: Brigham researchers develop smartphone-based Ovulation Test 71
6.26 Dec 10, 2018: New member proposed for election to Roche Board of Directors 72
6.27 Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019 72
6.28 Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent 73
6.29 Nov 30, 2018: European Patent granted for Colli-Pee 73
6.30 Nov 29, 2018: Australian TGA approves Atomo HIV Self Test as first rapid diagnostic test for home use 73
6.31 Nov 28, 2018: INSTI HIV Self Test earns WHO prequalification status for home testing 74
6.32 Nov 08, 2018: Colli-Pee approved by Mexican Health Authority 75
6.33 Oct 31, 2018: Biocept announces new executive hires to its sales and marketing organization 76
6.34 Oct 25, 2018: Exeltis Spain launches the world’s first ever digital urology solution 77
7 Appendix 78
7.1 Methodology 78
7.2 About GlobalData 81
7.3 Contact Us 81
7.4 Disclaimer 81

List of Tables
Table 1: Self Testing - Pipeline Products by Stage of Development 7
Table 2: Self Testing - Pipeline Products by Territory 8
Table 3: Self Testing - Pipeline Products by Regulatory Path 9
Table 4: Self Testing - Pipeline Products by Estimated Approval Date 10
Table 5: Self Testing - Ongoing Clinical Trials 11
Table 6: Self Testing Companies - Pipeline Products by Stage of Development 12
Table 7: Self Testing - Pipeline Products by Stage of Development 13
Table 8: Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 14
Table 13: bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 16: Boston Microfluidics Pipeline Products & Ongoing Clinical Trials Overview 20
Table 19: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 21
Table 22: Emory University Pipeline Products & Ongoing Clinical Trials Overview 22
Table 25: Entia Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
Table 28: InnaMed Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 35: Morgan Innovation And Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
Table 38: Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview 27
Table 41: OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 28
Table 44: Premier Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
Table 47: Shanghai Kehua Bio-engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
Table 50: Svenska Cellulosa Aktiebolaget Pipeline Products & Ongoing Clinical Trials Overview 31
Table 53: Tasso, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 56: Wellmetrix LLC Pipeline Products & Ongoing Clinical Trials Overview 33
Table 59: Glossary 80

List of Figures
Figure 1: Self Testing - Pipeline Products by Stage of Development 7
Figure 2: Self Testing - Pipeline Products by Territory 8
Figure 3: Self Testing - Pipeline Products by Regulatory Path 9
Figure 4: Self Testing - Pipeline Products by Estimated Approval Date 10
Figure 5: Self Testing - Ongoing Clinical Trials 11

【掲載企業】

Atomo Diagnostics Pty Ltd
bioLytical Laboratories Inc
Boston Microfluidics
Brigham and Women's Hospital
Emory University
Entia Ltd
InnaMed Inc
Morgan Innovation And Technology Ltd
Novosanis NV
OncoGenesis
Premier Medical Corporation
Shanghai Kehua Bio-engineering Co Ltd
Svenska Cellulosa Aktiebolaget
Tasso, Inc.
Wellmetrix LLC

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[自己テスト:医療機器パイプライン分析2019]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆